Bold Health Partners with the University of Pennsylvania for Clinical Trial of Its Zemedy IBS App

The School of Arts and Science of the prestigious University of Pennsylvania invites participants to a waitlist randomised control trial investigating the potential benefits of the Zemedy mobile app in patients with Irritable Bowel Syndrome (IBS). “We have been tremendously fortunate to partner with Dr Hunt in both creating the innovative intervention based on her research…

MedShr News: It’s about the talk, not the tech

This Autumn has been a whirlwind for MedShr, with an exciting award nomination recognising MedShr’s social impact, the opportunity to be part of the prestigious Vienna Health Hub, and our name on the list of the UK’s top tech scale-up businesses.  As a “tech scale-up”, it’s easy enough to imagine that our accomplishments have been…